The HHS has awarded Moderna $176 million to expand its capabilities to develop mRNA-based pandemic influenza vaccines.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
The HHS has awarded Moderna $176 million to expand its capabilities to develop mRNA-based pandemic influenza vaccines.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis